Cas no 2227205-29-8 ((5-Chloropyrimidin-2-yl)methanol hydrochloride)

(5-Chloropyrimidin-2-yl)methanol hydrochloride is a versatile chemical intermediate used in pharmaceutical and agrochemical synthesis. Its pyrimidine core structure makes it valuable for constructing biologically active compounds, particularly in the development of kinase inhibitors and antimicrobial agents. The hydrochloride salt form enhances stability and solubility, facilitating handling and reaction efficiency. The chloropyrimidine moiety allows for further functionalization via nucleophilic substitution or cross-coupling reactions, offering flexibility in synthetic applications. This compound is characterized by high purity and consistent performance, making it suitable for research and industrial-scale processes. Proper storage under anhydrous conditions is recommended to maintain its integrity.
(5-Chloropyrimidin-2-yl)methanol hydrochloride structure
2227205-29-8 structure
Product Name:(5-Chloropyrimidin-2-yl)methanol hydrochloride
CAS No:2227205-29-8
MF:C5H6Cl2N2O
MW:181.01993894577
MDL:MFCD31925842
CID:5174584
Update Time:2026-03-04

(5-Chloropyrimidin-2-yl)methanol hydrochloride Chemical and Physical Properties

Names and Identifiers

    • (5-Chloropyrimidin-2-yl)methanol hydrochloride
    • (5-Chloropyrimidin-2-yl)methanol;hydrochloride
    • P20449
    • MDL: MFCD31925842
    • Inchi: 1S/C5H5ClN2O.ClH/c6-4-1-7-5(3-9)8-2-4;/h1-2,9H,3H2;1H
    • InChI Key: GTQHXYBZPINSSB-UHFFFAOYSA-N
    • SMILES: ClC1C=NC(CO)=NC=1.Cl

Computed Properties

  • Hydrogen Bond Donor Count: 2
  • Hydrogen Bond Acceptor Count: 3
  • Heavy Atom Count: 10
  • Rotatable Bond Count: 1
  • Complexity: 83
  • Topological Polar Surface Area: 46

(5-Chloropyrimidin-2-yl)methanol hydrochloride Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
NAN JING YAO SHI KE JI GU FEN Co., Ltd.
PBN20120202-1-100.0mg
(5-chloropyrimidin-2-yl)methanol hydrochloride
2227205-29-8 97%
100.0mg
¥482.0000 2025-04-11
NAN JING YAO SHI KE JI GU FEN Co., Ltd.
PBN20120202-1-250.0mg
(5-chloropyrimidin-2-yl)methanol hydrochloride
2227205-29-8 97%
250.0mg
¥647.0000 2025-04-11
NAN JING YAO SHI KE JI GU FEN Co., Ltd.
PBN20120202-1-500.0mg
(5-chloropyrimidin-2-yl)methanol hydrochloride
2227205-29-8 97%
500.0mg
¥1076.0000 2025-04-11
NAN JING YAO SHI KE JI GU FEN Co., Ltd.
PBN20120202-1-1.0g
(5-chloropyrimidin-2-yl)methanol hydrochloride
2227205-29-8 97%
1.0g
¥1611.0000 2025-04-11
eNovation Chemicals LLC
Y1096929-1G
(5-chloropyrimidin-2-yl)methanol hydrochloride
2227205-29-8 97%
1g
$260 2024-07-21
SHANG HAI HAO HONG Biomedical Technology Co., Ltd.
1256065-1g
(5-Chloropyrimidin-2-yl)methanol hydrochloride
2227205-29-8 98%
1g
¥2107 2023-04-06
eNovation Chemicals LLC
Y1096929-1G
(5-chloropyrimidin-2-yl)methanol hydrochloride
2227205-29-8 97%
1g
$260 2025-02-27
NAN JING YAO SHI KE JI GU FEN Co., Ltd.
PBN20120202-1-1G
(5-chloropyrimidin-2-yl)methanol hydrochloride
2227205-29-8 95%
1g
¥ 1,610.00 2023-04-05
eNovation Chemicals LLC
Y1096929-1g
(5-chloropyrimidin-2-yl)methanol hydrochloride
2227205-29-8 97%
1g
$260 2025-02-28

Additional information on (5-Chloropyrimidin-2-yl)methanol hydrochloride

Chemical Profile of (5-Chloropyrimidin-2-yl)methanol Hydrochloride (CAS No. 2227205-29-8)

(5-Chloropyrimidin-2-yl)methanol hydrochloride, also known by its CAS number 2227205-29-8, is a compound of significant interest in the fields of organic chemistry and pharmacology. This compound belongs to the class of pyrimidine derivatives, which have been extensively studied due to their diverse biological activities and potential applications in drug development. The molecule consists of a pyrimidine ring substituted with a chlorine atom at the 5-position and a hydroxymethyl group at the 2-position, which is further protonated to form the hydrochloride salt.

The synthesis of (5-Chloropyrimidin-2-yl)methanol hydrochloride typically involves multi-step organic reactions, often starting from readily available pyrimidine precursors. Recent advancements in synthetic methodologies have enabled the efficient preparation of this compound with high purity, making it more accessible for research purposes. The compound's structure has been confirmed through various spectroscopic techniques, including NMR, IR, and mass spectrometry, ensuring its identity and quality.

In terms of biological activity, (5-Chloropyrimidin-2-yl)methanol hydrochloride has shown promising results in preliminary studies. It exhibits potential as a kinase inhibitor, which is a critical target in the development of anticancer agents. Recent research has highlighted its ability to modulate specific signaling pathways involved in cell proliferation and apoptosis, suggesting its role in antitumor therapies. Additionally, the compound has demonstrated moderate antimicrobial activity against various bacterial strains, indicating its potential use in antibacterial drug design.

The pharmacokinetic properties of (5-Chloropyrimidin-2-yl)methanol hydrochloride have also been investigated, revealing favorable absorption and bioavailability profiles. These findings are crucial for its consideration as a lead compound in preclinical studies. Furthermore, toxicological evaluations have shown that the compound exhibits low toxicity at therapeutic concentrations, which is a positive indicator for its safety profile.

Recent studies have explored the use of (5-Chloropyrimidin-2-yl)methanol hydrochloride as a building block for more complex molecular architectures. By leveraging its structural features, researchers have successfully synthesized novel analogs with enhanced biological activities. For instance, modifications to the substituents on the pyrimidine ring have led to compounds with improved potency against specific targets.

In conclusion, (5-Chloropyrimidin-2-yl)methanol hydrochloride (CAS No. 2227205-29-8) represents a valuable compound with diverse applications in medicinal chemistry. Its unique structure, coupled with promising biological activities, positions it as a compelling candidate for further exploration in drug discovery programs. As research continues to uncover its full potential, this compound is expected to contribute significantly to the development of novel therapeutic agents.

Recommended suppliers
Zhengzhou Baoyu Pharmaceutical Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Zhengzhou Baoyu Pharmaceutical Co., Ltd.
Henan Dongyan Pharmaceutical Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Henan Dongyan Pharmaceutical Co., Ltd
Xiamen PinR Bio-tech Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Xiamen PinR Bio-tech Co., Ltd.
Yunnanjiuzhen
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Yunnanjiuzhen
Hebei Liye chemical Co.,Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Hebei Liye chemical Co.,Ltd